NIH-funded research R21 grant

Investigating neuroinflammation in schizophrenia using advanced MRI techniques

Official title: Validation of Diffusion Basis Spectrum Imaging of Neuroinflammation in Schizophrenia

Funded at Washington University · NIH-10745333 · Data updated 2026-11-12

This study is looking at how inflammation in the brain affects schizophrenia, especially in young adults, by testing a new MRI method that can spot these changes without any surgery, which could help doctors diagnose and treat the condition more effectively.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startDecember 1, 2022
Project endOctober 31, 2025
Funding year2024
Award (this year)$194,375
NIH project number5R21MH131962-02
Project IDNIH-10745333 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 18-30 who have been diagnosed with schizophrenia.

Less likely to help

Patients outside the age range of 18-30 or those without a diagnosis of schizophrenia may not benefit from this research.

What this research studies

This research focuses on understanding the role of neuroinflammation in schizophrenia, a complex brain disorder that often begins in late adolescence. The team aims to validate a new MRI technique called Diffusion Basis Spectrum Imaging (DBSI), which can non-invasively detect neuroinflammation and related brain changes. By analyzing postmortem brain samples from young adults with schizophrenia, the researchers hope to establish a link between DBSI findings and neuroinflammation, potentially leading to earlier diagnosis and better treatment options.

Why it matters

Potential benefit: If successful, this research could lead to improved early detection and treatment strategies for schizophrenia, enhancing patient outcomes.

How similar studies have gone: Previous research has successfully validated DBSI in conditions like multiple sclerosis and Alzheimer's disease, suggesting a promising approach for schizophrenia.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Mamah, Daniel — Washington University
  • Study coordinator: Mamah, Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.